Table 2 Rates of Prescribing ChEIs and Memantine
From: Clinicians’ prescription preferences for treating patients with Alzheimer’s disease in Shanghai
Drug Characteristics | Psychiatrists (n = 39) | Neurologists (n = 66) | General physicians (n = 43) | F/X 2 | P value |
|---|---|---|---|---|---|
ChEIs, n (%) | 37(94.9) | 65(98.5) | 41(95.2) | 1.605 | 0.601 |
Donepezil, n (%) | 20(51.3) | 60(90.9) | 21(48.8) | 28.295 | 0.000 |
Dose (mg/day), mean(SD) | 5.75 ± 1.832 | 5.67 ± 1.714 | 5.24 ± 1.091 | 0.651 | 0.524 |
Rivastigmine, n (%) | 1(2.6) | 18(27.3) | 4(9.3) | 13.200 | 0.001 |
Dose (mg/day), mean(SD) | 6.00 ± 0.000 | 5.83 ± 2.515 | 5.25 ± 2.872 | 0.090 | 0.915 |
Galanthamine, n (%) | 7(17.9) | 11(16.7) | 1(2.3) | 6.022 | 0.049 |
Dose (mg/day), mean(SD) | 15.43 ± 2.760 | 14.91 ± 4.764 | 12.00 ± 0.000 | 0.303 | 0.743 |
Huperzine A, n (%) | 34(87.2) | 45(68.2) | 28(65.1) | 5.978 | 0.050 |
Dose (ug/day), mean(SD) | 280.88 ± 81.66 | 263.33 ± 89.443 | 278.57 ± 95.674 | 0.456 | 0.635 |
Memantine, n(%) | 8(20.5) | 39(59.1) | 9(20.9) | 22.878 | 0.000 |
Dose (mg/day), mean(SD) | 11.88 ± 4.581 | 11.15 ± 4.209 | 11.67 ± 2.500 | 0.140 | 0.870 |